
Praxis Precision Medicines Inc
PRAXNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$352.63
Day High
$355.00
Day Low
$338.07
Prev. Close
$352.63
VolumeShares traded today.
361.94K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$9.76B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-26.18
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$366.52
52W LowLowest price over the past 52 weeks.
$37.19
50D MAAverage closing price over the last 50 trading days.
$326.64
200D MAAverage closing price over the last 200 trading days.
$229.96
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
-0.2%1M
+8.3%6M
+89.9%YTD
+22.2%1Y
+807.8%About
Ulixacaltamide is an investigational new drug developed by Praxis Precision Medicines for the treatment of essential tremor (ET). It is a small molecule designed to selectively inhibit T-type calcium channels, reducing the abnormal neuronal burst firing in the cerebello-thalamo-cortical (CTC) circuit that is believed to cause tremors.
praxismedicines.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade PRAX
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.